BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10516135)

  • 1. Acute effect of growth hormone to induce peripheral insulin resistance is independent of FFA and insulin levels in rats.
    Kim JK; Choi CS; Youn JH
    Am J Physiol; 1999 Oct; 277(4):E742-9. PubMed ID: 10516135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
    Kim JK; Wi JK; Youn JH
    Diabetes; 1996 Apr; 45(4):446-53. PubMed ID: 8603766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
    Koopmans SJ; Kushwaha RS; DeFronzo RA
    Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of FFA on insulin-stimulated glucose fluxes and muscle glycogen synthase activity in rats.
    Park JY; Kim CH; Hong SK; Suh KI; Lee KU
    Am J Physiol; 1998 Aug; 275(2):E338-44. PubMed ID: 9688637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 13C and 31P NMR studies on the effects of increased plasma free fatty acids on intramuscular glucose metabolism in the awake rat.
    Jucker BM; Rennings AJ; Cline GW; Shulman GI
    J Biol Chem; 1997 Apr; 272(16):10464-73. PubMed ID: 9099689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged suppression of glucose metabolism causes insulin resistance in rat skeletal muscle.
    Kim JK; Youn JH
    Am J Physiol; 1997 Feb; 272(2 Pt 1):E288-96. PubMed ID: 9124337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of fatty acid-induced inhibition of glucose uptake.
    Boden G; Chen X; Ruiz J; White JV; Rossetti L
    J Clin Invest; 1994 Jun; 93(6):2438-46. PubMed ID: 8200979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic impairment precedes insulin resistance in skeletal muscle during high-fat feeding in rats.
    Kim JK; Wi JK; Youn JH
    Diabetes; 1996 May; 45(5):651-8. PubMed ID: 8621018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of free fatty acids on glucose uptake and utilization in healthy women.
    Homko CJ; Cheung P; Boden G
    Diabetes; 2003 Feb; 52(2):487-91. PubMed ID: 12540625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic control analysis of insulin-stimulated glucose disposal in rat skeletal muscle.
    Jucker BM; Barucci N; Shulman GI
    Am J Physiol; 1999 Sep; 277(3):E505-12. PubMed ID: 10484363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo.
    Pereira S; Park E; Moore J; Faubert B; Breen DM; Oprescu AI; Nahle A; Kwan D; Giacca A; Tsiani E
    Appl Physiol Nutr Metab; 2015 Nov; 40(11):1129-36. PubMed ID: 26455923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate induces insulin resistance in skeletal muscle by suppressing glycolysis and impairing insulin signaling.
    Choi CS; Kim YB; Lee FN; Zabolotny JM; Kahn BB; Youn JH
    Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E233-40. PubMed ID: 12110527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal.
    Hawkins M; Barzilai N; Chen W; Angelov I; Hu M; Cohen P; Rossetti L
    Diabetes; 1996 Dec; 45(12):1734-43. PubMed ID: 8922359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the glucosamine pathway in fat-induced insulin resistance.
    Hawkins M; Barzilai N; Liu R; Hu M; Chen W; Rossetti L
    J Clin Invest; 1997 May; 99(9):2173-82. PubMed ID: 9151789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of growth hormone-releasing factor stimulated growth hormone secretion by plasma glucose and free fatty acid concentrations in sheep.
    Sartin JL; Bartol FF; Kemppainen RJ; Dieberg G; Buxton D; Soyoola E
    Neuroendocrinology; 1988 Dec; 48(6):627-33. PubMed ID: 3150778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediation of the hepatic effects of growth hormone by its lipolytic activity.
    Piatti PM; Monti LD; Caumo A; Conti M; Magni F; Galli-Kienle M; Fochesato E; Pizzini A; Baldi L; Valsecchi G; Pontiroli AE
    J Clin Endocrinol Metab; 1999 May; 84(5):1658-63. PubMed ID: 10323396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the insulin-antagonistic effect of growth hormone in insulin-dependent diabetes mellitus.
    Fowelin J; Attvall S; von Schenck H; Smith U; Lager I
    Diabet Med; 1995 Nov; 12(11):990-6. PubMed ID: 8582132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin suppresses PDK-4 expression in skeletal muscle independently of plasma FFA.
    Lee FN; Zhang L; Zheng D; Choi WS; Youn JH
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E69-74. PubMed ID: 15026305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
    Rebrin K; Steil GM; Mittelman SD; Bergman RN
    J Clin Invest; 1996 Aug; 98(3):741-9. PubMed ID: 8698866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.